February 1, 2021
AliveCor has updated the capabilities of its mobile ECG devices to identify three additional types of heart conditions, the company announced today.
Sinus rhythm with supraventricular ectopy (SVE), sinus rhythm with premature ventricular contractions (PVCs) and sinus rhythm with wide QRS are now all on the table of AliveCor's KardiaMobile line of ECG devices, which already detected atrial...
December 8, 2020
Apple has landed a new FDA clearance for an updated version of its ECG feature, allowing the tool to add a category called A-Fib with high heart rate.
This comes a little over two years after Apple first landed a De Novo clearance for its first version of the ECG reading.
The latest version of the ECG feature will be available when the new software update rolls out. This second generation will...
September 23, 2020
A one-sided arrangement. Earlier this week, budget-minded connected-exercise-maker Echelon Fitness announced the launch of is "Prime Bike," a $499 device that it described in its reveal as "Amazon's first-ever connected fitness product." Through a bring-your-own-tablet interface, the machine would enable owners to join live and on-demand fitness classes through Echelon's subscription service.
September 7, 2020
French digital firm Withings today announced that its latest wearable is available in Europe, after receiving the CE marking for medical devices.
Developed by cardiologists and sleep experts, Withings says that ScanWatch is the world's first clinically validated hybrid smartwatch to detect both atrial fibrillation (AFib) and overnight breathing disturbances.
The smart watch is designed to help...
May 6, 2020
Fitbit announced this morning the launch of a new atrial fibrillation research study aiming to enroll hundreds of thousands of fitness-tracker and smartwatch owners.
Called the Fitbit Heart Study, it will passively and continuously monitor wearers' heart rates using the devices' photoplethysmography (PPG) sensors. A proprietary algorithm will interpret these readings and flag potential...
April 1, 2020
Belgium-based FibriCheck, the maker of apps that monitor a user's heart rhythm, announced yesterday that it has developed a new version of its smartwatch offering that is capable of scanning for atrial fibrillation while the wearer is asleep.
FibriCheck said in a release that the updated app is currently nearing the end of user testing, and that it will be available for smartwatch manufacturers...
January 28, 2020
This morning digital cardiac health startup Eko announced that its atrial fibrillation and heart murmur detection algorithm landed a 510(k) FDA clearance. The new algorithms are designed to integrate with Eko’s stethoscope, which is already on the market, and be used by healthcare providers.
The company said it plans to add more algorithms in the future. Next up will be an ECG-based algorithm...
January 2, 2020
On Apple and patents. A New York University School of Medicine cardiologist is unhappy with Apple Watch’s heart rate irregularity detection feature, which he claims in a new lawsuit infringes his own patent for atrial fibrillation detection technology. Filed in the US District Court for the Eastern District of New York on December 27, 2019, the suit describes Dr. Joseph Wiesel’s invention and his...
September 24, 2019
Fitbit and Belgium-based FibriCheck announced today that device owners living in certain UK countries now have access to a smartwatch app that uses photoplethysmography (PPG) to detect heart rhythm irregularities such as atrial fibrillation.
Available in Belgium, the UK, the Netherlands and Ireland, the CE-marked tool is similar to FibriCheck’s smartphone app in that it uses light and sensors to...
September 5, 2019
Alphabet’s life science branch Verily is teaming up with digital health startup iRhythm on a new initiative focused on creating screening, diagnosis and management tools for patients with atrial fibrillation.
The collaboration is specifically targeted at alerting patients with asymptomatic or silent atrial fibrillation about their condition. The goal is to develop products that not only identify...